Reporting owner · CIK 0001424383

Germano Geno J

SEC Form 4 history for the last 180 days across 2 companies, 5 transactions and 4 filings.

DIREloxx Pharmaceuticals, Inc.
Open-market transaction mix100% buys1 buy · 0 sales

Period: Last 180 days

Trade dates in this period: May 20, 2026 – Oct 19, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings4Form 4 records
Buying$16.4k1 purchase
Selling$00 sales
Net value+$16.4kBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Germano Geno J transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
ELOXEloxx Pharmaceuticals, Inc.
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Derivative securitySEC filing ↗
$0View disclosure →
DTILPRECISION BIOSCIENCES INC
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
SEC filing ↗
$16.4kView disclosure →
DTILPRECISION BIOSCIENCES INC
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Derivative securitySEC filing ↗
$0View disclosure →
DTILPRECISION BIOSCIENCES INC
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
DTILPRECISION BIOSCIENCES INC
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
—View disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a buy at PRECISION BIOSCIENCES INC on Sep 25, 2026 valued at $16,384.52.

Review SEC filing
Latest sale

No open-market insider sale is available.

Monthly open-market activity

Last 4 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
May 202600$0$0$0
Jun 202600$0$0$0
Sep 202610$16,384.52$0+$16,384.52
Oct 202600$0$0$0

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$16.4k
Median P/S size$16.4k
Direct5
Indirect0
Oct 19, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

2 observations · May 20, 2026 – Sep 25, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 25, 202647,492 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
May 20, 202644,883May 22, 2026View transaction
Sep 25, 202647,492Sep 29, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Germano Geno J Insider Activity FAQ

SEC Form 4 context

Who is Germano Geno J?

Germano Geno J is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001424383.

Which companies has Germano Geno J reported transactions for?

Eloxx Pharmaceuticals, Inc., PRECISION BIOSCIENCES INC, Entera Bio Ltd.

When was Germano Geno J's latest insider buy?

The insider reported a buy at PRECISION BIOSCIENCES INC on Sep 25, 2026 valued at $16,384.52.

When was Germano Geno J's latest insider sale?

No open-market insider sale is recorded in the last 180 days. Earlier filings are outside the visible history.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.